Evidence map›Paper›PMID 33528741›Full record

SynthesisCurrent HIV/AIDS reports2021

Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review.

Michalina A Montaño, Maganizo B Chagomerana, Margaret Borok, Matthew Painschab, Thomas S Uldrick, Rachel A Bender Ignacio

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Current HIV/AIDS reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Côte d'Ivoire: A prospective cohort study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Michalina A MontañoDepartment of Biochemistry, University of Washington, Box 357236, Seattle, WA, 98195, USA. micham@uw.edu.ORCID 0000-0003-2872-1929
Maganizo B ChagomeranaUNC Project-Malawi, Tidziwe Centre, Private Bag A-104, Lilongwe, Malawi.
Margaret BorokDepartment of Medicine, University of Zimbabwe College of Health Sciences, MP 167, Mount Pleasant, Harare, Zimbabwe.
Matthew PainschabDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Thomas S UldrickGlobal Oncology Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., D5-310, Seattle, WA, 98109, USA.
Rachel A Bender IgnacioVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
University of North Carolina at Chapel Hill · USUniversity of Washington · USFred Hutch Cancer Center · USUniversity of Zimbabwe · ZW

Funding

The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.U54CA254564 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2020 to 2024
$6.1M
Project 3U54CA190152 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A, GOPAL, SATISH · 2014 to 2019
$4.2M
Safety, efficacy, and cost-effectiveness of rituximab for multicentric Castleman disease in MalawiK01TW011470 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PAINSCHAB, MATTHEW SCOTT · 2019 to 2023
$720k
Addressing the burden of untreated HIV in cancer patients in sub-Saharan Africa: feasibility and planning for a pragmatic clinical trialR21AI155055 · NIAID · UNIVERSITY OF WASHINGTON · PI BENDER IGNACIO, RACHEL ANN · 2021 to 2022
$330k
FIC NIH HHS K01 TW011470FIC NIH HHS L30 TW011802NCI NIH HHS L30 CA233709NCI NIH HHS U54 CA190152NCI NIH HHS U54 CA254564NIAID NIH HHS R21 AI155055
6 · The paper itself

Abstract

purpose of reviewThe relationship between antiretroviral therapy (ART) and cancer treatment outcomes among people living with HIV (PLWH) in low- and middle-income countries (LMICs) is complex and poorly understood for many cancers. We aimed to summarize existing evidence from LMICs regarding the benefit of ART on cancer treatment-related outcomes. RECENT

findingsWe included twelve observational studies that reported associations between ART status and cancer treatment outcomes among HIV-positive patients in LMICs. Most confirmed ART was associated with improved cancer treatment outcomes. Heterogeneity in cancers under study, outcome measurement, categorization of ART status, and reporting of HIV-related immune function made formal comparison between studies untenable. Where evaluated, ART generally has a positive effect on cancer outcomes in people with HIV in LMICs. However, there remains a substantial gap in the literature regarding the impact of ART on treatment outcomes for most cancer types. Future research should focus on the optimal timing and integration of ART and cancer treatment for PLWH with strategies applicable to constrained-resource settings.

Indexed as

Anti-HIV AgentsHIV InfectionsNeoplasmsDeveloping CountriesHumansPovertyTreatment OutcomeAnti-HIV AgentsAntiretroviral therapyCancerHIVLMICTreatment outcomes

Identifiers

PMID33528741
PMCPMC10227634
OpenAlexW3126946923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.